Terms & Conditions

Virtus Pharmaceuticals, LLC, (“Virtus”) and Acertis Pharmaceuticals, LLC, (“Acertis”) operate certain Websites (the “Virtus and Acertis Websites”) for the purpose of personal information and education. The health information contained in the Virtus and Acertis Websites are provided for educational purposes only and are not intended to replace discussions with a physician or other healthcare provider. Your use of a Virtus and Acertis Website constitutes your acceptance without modification of the terms, conditions, and notices contained herein and all applicable laws. Your use of a particular Virtus and Acertis Website included within the Virtus and Acertis Websites network may also be subject to additional terms outlined elsewhere on that Website.

Use of Site

Virtus and Acertis hereby authorizes you to copy documents published by Virtus and Acertis on the World Wide Web for noncommercial use by you or your organization only, provided any copy of these documents you make shall retain all copyright and other proprietary notices contained therein.

Nothing contained herein shall be construed as conferring, by implication, estoppel, or otherwise, any license or right under any patent or trademark of Virtus and Acertis or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right under any Virtus copyright.

Should any viewer of a Virtus and Acertis published document respond with information including feedback data, such as questions, comments, suggestions, or the like regarding the content of any such Virtus and Acertis document, such information shall be deemed to be non-confidential, and Virtus and Acertis shall have no obligation of any kind with respect to such information and shall be free to reproduce, use, disclose, and distribute the information to others without limitation. Virtus and Acertis shall be free to use any ideas, concepts, know-how, or techniques contained in such information for any purpose whatsoever including but not limited to developing, manufacturing, and marketing products incorporating such information.

Claims

Each claim or statement about the safety or effectiveness of Virtus and Acertis products and each claim or statement comparing the safety or effectiveness of Virtus and Acertis products to the safety or effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Website. When inquiring about a specific product, always refer to the full package insert for the most up-to-date safety and indications information.

Third-Party Links

In an attempt to provide increased value to our visitors, the Virtus and Acertis Websites may contain links to other Websites on the Internet that are owned and operated by third-party vendors and other third parties. However, even if the third party is affiliated with Virtus and Acertis, Virtus and Acertis have no control over these linked Websites, all of which have separate privacy and data collection practices independent of Virtus and Acertis. Virtus and Acertis make no claim or representation regarding, and accepts no responsibility for the quality, content, nature, or reliability of Websites accessible by hyperlink from the Virtus and Acertis Websites or Websites linking to the Virtus and Acertis Websites.

The linked Websites are not under the control of Virtus and Acertis, and Virtus and Acertis are not responsible for the contents of any linked Website or any link contained in a linked Website, or any review, changes or updates to such Websites. Virtus and Acertis are providing these links to you only as a convenience, and the inclusion of any link does not imply affiliation, endorsement, or adoption by Virtus and Acertis of the Website or any information contained therein. These linked Websites are only for your convenience, and, therefore, you access them at your own risk.

Disclaimer and Limitation of Liability

Virtus and Acertis make no warranties or representations about the accuracy or completeness of the Virtus Website’s content or the content of any linked Websites. This publication is provided “AS IS” WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. VIRTUS AND ACERTIS DO NOT REPRESENT OR WARRANT THAT MATERIALS ON THIS WEBSITE ARE ACCURATE, COMPLETE, RELIABLE, CURRENT, OR ERROR-FREE. VIRTUS DOES NOT REPRESENT OR WARRANT THAT THIS WEBSITE OR ITS SERVER(S) ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. Some jurisdictions do not allow the exclusion of implied warranties, so the above exclusion may not apply to you.

IN NO EVENT SHALL VIRTUS BE LIABLE FOR ANY DIRECT, SPECIAL, INDIRECT, OR CONSEQUENTIAL DAMAGES, OR ANY OTHER DAMAGES OF ANY KIND INCLUDING, BUT NOT LIMITED TO, LOSS OF USE, LOSS OF PROFITS, OR LOSS OF DATA, WHETHER IN AN ACTION IN CONTRACT, TORT (INCLUDING, BUT NOT LIMITED TO, NEGLIGENCE), OR OTHERWISE, ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE USE OF THIS WEBSITE OR THE MATERIALS CONTAINED ON, OR ACCESSED THROUGH, THIS WEBSITE.

Applicable Law

These terms and conditions shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its choice of law principles.

Anthony W. Amato

Chief Executive Officer

After practicing law for several years, Tony started his career in pharmaceuticals in business development at Barr Labs. During his tenure at the company, Barr acquired proprietary women’s health products, Plan B and Paragard, and in-licensed transdermals, ophthalmics and nasal sprays, rapidly expanding beyond its generic solid oral dose portfolio. Barr was eventually acquired by Teva for $7.5B in 2008. Tony next headed up US business development at Lupin Pharmaceuticals and led the aggressive expansion into high margin brand products, diversifying Lupin’s product portfolio. In 2014 Tony joined Alvogen and rose to the position of Sr. Vice President Business Development and Alliance Management, completing multiple transactions and deploying over $500M capital in five years to expand the generic portfolio into injectables and inhalation drug forms and grow its branded business, Almatica, through the acquisition of highly profitable mature products and patent protected Psychiatry/CNS approved and pipeline products as well as biosimilars.

Tony was named CEO of Virtus in 2022 and is re-positioning the company by building verticals focused on retail and institutional generics, brands, consumer health and biosimilars, employing innovative business models and deal structures that will benefit its partners and, ultimately, patients.

Debra Cesard

Chief Financial Officer

Debra re-joined Virtus as Chief Financial Officer in March 2022, previously serving in that role through 2020. She is an accomplished financial manager with 25+ years of experience having previously worked for a “Big 4” accounting firm and emerging and established global brand and generic pharmaceutical companies including AdvaGen, Sandoz and Bristol-Myers Squibb. She possesses outstanding problem-solving abilities and impeccable integrity. A strategic-minded yet hands-on leader recognized for establishing cross functional collaboration as a business partner, initiating and managing change, developing high performing teams, as well as planning and executing corporate strategies and company- wide initiatives.

Debra is a Certified Public Accountant (inactive) and holds a Bachelor of Science in Accounting from Rutgers University.

Michael Proctor

Head of Promoted Products

Michael “Mickey” Proctor joined Virtus Pharmaceuticals, LLC in January 2022 as Head of Promoted Products. Mickey is an experienced veteran of the pharmaceutical industry with 43+ years of experience with brands and generics and start-up to global leading companies. He has served in executive leadership positions for 20+ years building strong performance teams among sales, marketing, managed care and account management. He created the commercial organization and launched the Suprax® brand to exceed $100M in a generic market with no patent protection.

Mickey holds a Bachelors of Arts and Bachelors of Science in Marketing, Ohio State University.

Myrl Vossler

Head of Generics

Myrl joined the company in February 2022, and serves as Head of Generics, Virtus Pharmaceuticals. He has 15 years of experience leading sales, marketing, and supply chain operations with new and established ventures across the pharmaceutical industry. Myrl has developed and executed numerous programs to successfully penetrate markets, retain accounts and control inventory while strengthening business relationships and profitability across key customers.

Myrl holds a Bachelor of Science degree from the University of Central Missouri.

Matthew Prokopczyk

Senior Vice President, Quality and Regulatory

Matthew serves as Senior Vice President, Quality and Regulatory, Virtus Pharmaceuticals bringing 25+ years of experience with brand and generic pharmaceutical companies. Prior to joining Virtus in February 2022, he held leadership positions of Quality and Regulatory functions at Aphena, Amerigen, Alvogen, Dr. Reddy’s and Wyeth. He is an accomplished veteran of the industry with a proven track record of building and leading compliant, efficient, quality organizations.

Matthew holds an MBA in Finance and Business Economics from Fordham University, NY and a Bachelor of Science Degree from the College of Mount Saint Vincent, NY.

Ashleigh Preiss

Vice President, Operations and Alliance Management

Ashleigh joined Virtus in August 2013 and serves as the Vice President, Operations and Alliance Management. She has extensive experience with the Virtus supply chain and logistics processes and partnerships to maintain inventory and support excellent customer service. Prior to her current role Ashleigh held positions of increasing responsibility as: Director, Supply Chain, Associate Director, Procurement and Logistics and Customer Service Analyst.

Ashleigh holds a Bachelors of Arts in Communication Sciences and Disorders, University of South Florida and a Bachelors of Science, Sport Management, California University, PA and is currently studying for a Master of Science in Public Health, Applied Studies, University of Florida Graduate School of Public Health and Certification in Production and Inventory Management (APICS).

Sandra Shook

Director of Human Resources

Sandra joined Virtus in April 2017 and serves as the Director of Human Resources. She has 25+ years of experience in human resource functions, issues, employment law and organizational development. She has served in positions of increasing responsibility with a specialty and global generic pharmaceutical leader. She is responsible for all human resource functions and objectives that provide an employee-oriented; high performance culture that emphasizes empowerment, quality productivity, standards and the recruitment and ongoing development of a superior workforce.

Sandra holds a Bachelor of Science in Business Administration, Albright College, PA

David Friedman

Head, Strategy and Business Development

David has over 30 years experience providing a wide range of corporate advisory services to clients in healthcare and related industries. Clients have included life sciences companies Novartis, Boehringer Ingelheim, Endo, Par Pharmaceutical, Lannett, Lupin, JHP Pharmaceuticals, G&W Laboratories and Ranbaxy. David holds a BA (History - Honors) from Haverford College and an MBA (Finance) from The Wharton School, University of Pennsylvania. He also studied at the London School of Economics.